Tezepelumab for severe asthma: elevating current practice to recognize epithelial driven profiles. Caminati M, Vatrella A, Rogliani P, Carpagnano E, et al. Respir Res 2024;25:367.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Caminati M, Vatrella A, Rogliani P, Carpagnano E, et al. Tezepelumab for severe asthma: elevating current practice to recognize epithelial driven profiles. Respir Res 2024;25:367.
PMID: 39385131